Literature DB >> 19164279

Grade-dependent proteomics characterization of kidney cancer.

Bertrand Perroud1, Tatz Ishimaru, Alexander D Borowsky, Robert H Weiss.   

Abstract

Kidney cancer is frequently metastatic on presentation at which point the disease is associated with a 95% mortality. Assessment of tumor grade on pathological examination is the most powerful means for prognostication as well as for stratification of patients into those who might respond to conventional or targeted therapy. Although there exist several grading systems in common use, all suffer from significant disparity among observers. In an attempt to objectify this process as well as to acquire grade-specific mechanistic information, we performed LC-MS/MS-based proteomics analysis on 50 clear cell kidney cancers equally distributed among normal tissues and Fuhrman grades 1-4. Initial experiments confirmed the utility of using archived formalin-fixed paraffin-embedded samples for LC-MS/MS-based proteomics analysis, and the LC-MS/MS findings were validated by extensive immunoblotting. We now show that changes among many biochemical processes and pathways are strongly grade-dependent with the glycolytic and amino acid synthetic pathways highly represented. In addition, proteins relating to acute phase and xenobiotic metabolism signaling are highly represented. Self-organized mapping of proteins with similar patterns of expression led to the creation of a heat map that will be useful in grade characterization as well as in future research relating to oncogenic mechanisms and targeted therapies for kidney cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164279      PMCID: PMC2689781          DOI: 10.1074/mcp.M800252-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  26 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance.

Authors:  Roland Kellner; Rudolf Lichtenfels; Derek Atkins; Jürgen Bukur; Angelika Ackermann; Joachim Beck; Walburgis Brenner; Sebastian Melchior; Barbara Seliger
Journal:  Proteomics       Date:  2002-12       Impact factor: 3.984

3.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

4.  PANTHER: a library of protein families and subfamilies indexed by function.

Authors:  Paul D Thomas; Michael J Campbell; Anish Kejariwal; Huaiyu Mi; Brian Karlak; Robin Daverman; Karen Diemer; Anushya Muruganujan; Apurva Narechania
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

Review 5.  Grading systems in renal cell carcinoma.

Authors:  Giacomo Novara; Guido Martignoni; Walter Artibani; Vincenzo Ficarra
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

6.  p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

Authors:  R H Weiss; A Joo; C Randour
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

7.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

8.  Fibrinogen precursors. Order of assembly of fibrinogen chains.

Authors:  S Yu; B Sher; B Kudryk; C M Redman
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

9.  Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect.

Authors:  Richard D Unwin; Rachel A Craven; Patricia Harnden; Sarah Hanrahan; Nick Totty; Margaret Knowles; Ian Eardley; Peter J Selby; Rosamonde E Banks
Journal:  Proteomics       Date:  2003-08       Impact factor: 3.984

10.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  54 in total

Review 1.  Urine metabolomics for kidney cancer detection and biomarker discovery.

Authors:  Sheila Ganti; Robert H Weiss
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

2.  Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis.

Authors:  Sheila Ganti; Sandra L Taylor; Omran Abu Aboud; Joy Yang; Christopher Evans; Michael V Osier; Danny C Alexander; Kyoungmi Kim; Robert H Weiss
Journal:  Cancer Res       Date:  2012-05-24       Impact factor: 12.701

3.  PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.

Authors:  Omran Abu Aboud; Dallas Donohoe; Scott Bultman; Mark Fitch; Tim Riiff; Marc Hellerstein; Robert H Weiss
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-25       Impact factor: 4.249

4.  A toolset to study functions of Cytosolic non-specific dipeptidase 2 (CNDP2) using Drosophila as a model organism.

Authors:  Evgeniya N Andreyeva; Anna A Ogienko; Tatiana D Dubatolova; Anastasiya L Oshchepkova; Elena N Kozhevnikova; Anton V Ivankin; Gera A Pavlova; Sergei A Kopyl; Alexey V Pindyurin
Journal:  BMC Genet       Date:  2019-03-18       Impact factor: 2.797

5.  Urinary acylcarnitines are altered in human kidney cancer.

Authors:  Sheila Ganti; Sandra L Taylor; Kyoungmi Kim; Charles L Hoppel; Lining Guo; Joy Yang; Christopher Evans; Robert H Weiss
Journal:  Int J Cancer       Date:  2011-09-14       Impact factor: 7.396

6.  Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.

Authors:  Kyoungmi Kim; Sandra L Taylor; Sheila Ganti; Lining Guo; Michael V Osier; Robert H Weiss
Journal:  OMICS       Date:  2011-02-24

Review 7.  Metabolic reprogramming in clear cell renal cell carcinoma.

Authors:  Hiromi I Wettersten; Omran Abu Aboud; Primo N Lara; Robert H Weiss
Journal:  Nat Rev Nephrol       Date:  2017-05-08       Impact factor: 28.314

8.  Formalin-Fixed, Paraffin-Embedded Tissues (FFPE) as a Robust Source for the Profiling of Native and Protease-Generated Protein Amino Termini.

Authors:  Zon Weng Lai; Juliane Weisser; Lars Nilse; Fabrizio Costa; Eva Keller; Martina Tholen; Jayachandran N Kizhakkedathu; Martin Biniossek; Peter Bronsert; Oliver Schilling
Journal:  Mol Cell Proteomics       Date:  2016-04-17       Impact factor: 5.911

Review 9.  Potential biofluid markers and treatment targets for renal cell carcinoma.

Authors:  Hiromi I Wettersten; Robert H Weiss
Journal:  Nat Rev Urol       Date:  2013-04-02       Impact factor: 14.432

10.  Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis.

Authors:  Josephine F Trott; Vicki J Hwang; Tatsuto Ishimaru; Kenneth J Chmiel; Julie X Zhou; Kyuhwan Shim; Benjamin J Stewart; Moe R Mahjoub; Kuang-Yu Jen; Dinesh K Barupal; Xiaogang Li; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.